Outset Halts Tablo Sales for Home Use Pending FDA Review of New Features
As Outset has added features improving Tablo since the FDA first cleared it for use, it has now had to submit another 510(k) application to the FDA, thus limiting sales to acute facilities only.
Read the full article » | Posted 07-13-2022
Related Articles
- Vantive: Real People, Real Stories on PD Empowers Site for Patients Posted 12-17-2025
- Medicare Fee Schedule Final Rule Summary: CY 2026 Posted 12-17-2025
- Medicare Deductible, Coinsurance & Premium Rates for 2026 Posted 12-17-2025
- Watch Dr. Joel Glickman’s ASN presentation on Home HD Prescriptions Posted 12-17-2025

